Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: MMP portfolio...

IMO there is nothing chisled in stone that states a company must license the entire MMP portfolio.  Yes, so far that has been the case and will probably continue to be the case... but this litigation brings exceptional circumstances.  The defendants may very well license the entire MMP portfolio.. but in order to get this case settled and dismissed, the defendants may be allowed to settle the '336 & '148... and then have to answer to '584 and the rest of the patents at a later date.

 

I humbly suggest that the litigation is no more exceptional for the remaining Defendants than it was for those who settled.

 

 

Be well

Share
New Message
Please login to post a reply